Hormone Receptor Positive Tumor Recruiting Phase 3 Trials for Exemestane (DB00990)

IndicationStatusPhase
DBCOND0075370 (Hormone Receptor Positive Tumor)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02404051Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast CancerTreatment